COBI--material definitive agreement---
The terms of the material definitive agreement provided that, in exchange for the Company's agreement to acquire all rights and obligations of GenBioPro, Inc., and its business of developing therapeutic women's products by virtue of licenses from Seraphim Life Sciences Consulting, LLC, Seraphim Bonaventures, Inc. and Sun Pharmaceuticals, Inc., the Company would assume a licensing fee payable to Seraphim Bonaventures,